Intelligence Driven Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Intelligence Driven Advisers's LLY Position: Q2 2026 in Review
Intelligence Driven Advisers increased its Eli Lilly (LLY) stake by 39% in Q2 2026, buying an estimated $189K and bringing the position to 661 shares worth $793K. The position accounts for 0.13% of the portfolio, ranked #59.
Intelligence Driven Advisers first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.59M in Q3 2024. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Intelligence Driven Advisers held 661 shares of Eli Lilly worth $793K as of Q2 2026.
- Intelligence Driven Advisers bought 185 Eli Lilly shares in Q2 2026, an estimated $189K.
- Eli Lilly made up 0.13% of Intelligence Driven Advisers's portfolio in Q2 2026, its #59 holding.
- Intelligence Driven Advisers first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- Intelligence Driven Advisers's Eli Lilly position peaked at $1.59M in Q3 2024.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Intelligence Driven Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.